H heterogenous population of hematopoietic precursor and progenitor cells. This broad array of cells, with differing phenotypic and functional properties, is thought to ultimately originate from primitive hematopoietic cells termed stem Hematopoietic stem cells (HSCs) have not only the ability to supply mature hematopoietic cells for prolonged periods of time, but are also able to generate a continuous supply of progeny stem cells, a process referred to as self-renewal. 7~~ To directly examine the properties of the human HSC, several laboratories, including our own, have attempted to develop multistep purification p r o c e d u r e~. l -~,~-~~ If this goal is accomplished, for the first time the cellular and molecular nature of HSCs may be directly examined. Several investigators, using a variety of in vitro and in vivo assays, have shown that an infrequent population of BM cells expressing CD34 and undetectable amounts of the class I1 major histocompatibility antigen, HLA-DR, possess many of the properties associated with HSCS.'~-'~ The primitive progenitor cells in this population lack expression of various other antigens associated with differentiated myeloid and lymphoid cells, have minimal uptake of Rhodamine 123 (R 123), a positively charged rhodamine analog that accumulates preferentially in cycling cells, and are resistant to in vitro treatment with 5-fluorouracil (5-FU).6J4 This phenotype is quite different from more differentiated progenitor cells that express both CD34 and HLA-DR, possess antigens associated with particular lineages, and are sensitive to in vitro 5-FU treatment.6J4
The ligand for the cellular proto-oncogene product, c-kit, is produced by marrow stromal cells, and is capable of influencing the proliferation and development of multiple hematopoietic lineages. 16-2y When acting in synergy with a number of cytokines, the c-kit ligand (JSL) is capable of profoundly promoting the proliferation of several classes of the most primitive human hematopoietic progenitor cells, CD34+ HLA-DR-SR-1+ cell population contained fewer of these more differentiated progenitor cells but exclusively contained the more primitive progenitor cells, the BFUmegakaryocyte, high proliferative potentiakolony-forming cell, and long-term bone marrow culture-initiating cell. The overall progenitor cell cloning efficiency of this subpopulation was greater than 7%. Both the CD34+ HLA-DR-and CD34+ HLA-DR+ cell subpopulations lacking KR expression contained few assayable hematopoietic progenitor cells. Long-term bone marrow cultures initiated with CD34+ HLA-DR-SR-l+ but not CD34+ HLA-DR-SR-1-cells, which were repeatedly supplemented with c-kit ligand (KL) and interleukin-3, generated assayable progenitor cells of a t least 2 lineages for 10 weeks. These experiments demonstrate the expression of the KR throughout the hierarchy of human hematopoietic progenitor cell development. We conclude from our data that the KL and KR play a pivotal role in cytokine regulation of both the primitive and more differentiated human hematopoietic progenitor cells. 0 1992 by The American Society of Hematology.
including the burst-forming unit-megakaryocyte (BFU-MK), high proliferative potential-colony forming cell (HPP-CFC), and long-term BM culture-initiating cell (LTBMC-IC). [30] [31] [32] [33] Recently, murine monoclonal antibodies (MoAbs) to the human and murine c-kit receptor ( of human hematopoietic progenitor ~e l l s . 3~ Furthermore, Ashman et al, using an immune rosetting technique and an MoAb to the human KR, have also shown that the human CFU-erythrocyte (CFU-E), BFU-E, CFU-granulocytemacrophage (CFU-GM),38 and CFU-granulocyte, erythrocyte, macrophage, megakaryocyte (CFU-GEMM) express KR? 8 We used a multistep MoAb staining protocol, including SR-1, and fluorescence-activated cell sorting (FACS) to further characterize the more primitive classes of human hematopoietic progenitor cells. These results indicate that the KR is expressed on both primitive and more differentiated human hematopoietic progenitor cells and that SR-1, in conjunction with CD34 and HLA-DR antibodies, may serve as a valuable tool in identifying and purifying both of these types of human hematopoietic progenitor cells.
MATERIALS AND METHODS
BM aspirates were obtained under local anesthesia from the posterior iliac crests of hematologically normal volunteers. Informed consent was obtained from the donors according to guidelines previously established by the Human Investigations Committee of the Indiana University School of Medicine, which adheres to the principles of the Declaration of Helsinki.
Cell Separation Techniques
BM aspirates were immediately diluted 1:l with Iscove's Modified Dulbecco's Media (IMDM; GIBCO Laboratories, Life Technologies, Inc, Grand Island, NY) containing 20 U sodium-heparin/ mL. Low-density mononuclear cells (LDMC) were obtained by density centrifugation over Ficoll-Paque (Pharmacia LKB Biotechnology Inc, Piscataway, NJ) at 75%. We further separated LDMC by counterflow centrifugal elutriation (CCE) to obtain those cells eluting at flow rates between 12 and 14 mL/min (FR 12-14;
The FR 12-14 cell population contained greater than 70% of progenitor cells as previously described by our laboratory.6
Mouse MoAbs
The following three purified mouse antihuman (m a h) MoAbs were used as immunologic probes for cell sorting experiments: (1) 
Cell Sorting Techniques
Cells were sorted on a Coulter Epics 753 dual laser flow cytometry system (Coulter Electronics, Hialeah, FL). Sorting gates were established for both forward angle light scatter (FALS) and TR fluorescence-positive events (CD34+). A dual-parameter histogram displaying FITC (SR-1) and phycoerythrin (PE) (HLA-DR) fluorescence was then generated from gated CD34+ events. Using this gated histogram, sorting windows were established for both positive and negative FITC and PE fluorescence. This gating procedure allowed for the isolation of four different cell populations: CD34+ HLA-DR-SR-1-; CD34+ HLA-DR-SR-l+; CD34+ HLA-DR+ SR-1-; and CD34+ HLA-DR+ SR-l+. The phenotypic purity of all four populations as determined by postsort flow cytometric analysis exceeded 95%.
The cells from each population were classified by performing differential cell counts on Wright-Giemsa-stained cytocentrifuge cell preparations using established morphologic criteria. Each population of cells was also assayed for various classes of human hematopoietic progenitor cells using procedures described below,6,9,39,40
Recombinant Human Hematopoietic Cytokines
The following three purified recombinant human hematopoietic cytokines were used as colony-stimulating factors in these experiments: (1) 
LTBMC System
LTBMCs lacking preestablished stromal cell layers were initiated and maintained as previously d e~c r i b e d ? .~~.~~ Briefly, 35-mm polystyrene tissue culture dishes containing 1 mL IMDM with 10% vol/vol fetal bovine serum (Hyclone, Logan, UT) were inoculated with lo4 of either the CD34+ HLA-DR-SR-1-or the CD34+ HLA-DR-SR-1+ marrow subpopulations obtained after FACS and incubated at 37°C in 100% humidified 5% COz in air. At this time, and every 48 hours thereafter: 1 mL cultures received both 1.0 ng IL-3 and 10.0 ng KL. To address the possibility that CD34+ HLA-DR-SR-1-cells might be responsive to other cytokines, we established LTBMCs initiated with these cells to which either GM-CSF/KL or FP/KL were added at 48-hour intervals. These two combinations proved to be inferior to the IL-3/KL combination in progenitor cell production and length of viable culture duration from LTBMCs. At weeks 2,4,6,8,10, and 12, the cultures For personal use only. on October 24, 2017. by guest www.bloodjournal.org From
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were demidepopulated by removal of one-half the culture volume, which was replaced with fresh media. Cells in the harvested media were counted, divided, and assayed in both of the subsequently described progenitor cell assay systems.
Progenitor Cell Assay Systems
Sorted cells, or cells harvested after the demidepopulation of LTBMCs, were assayed for their ability to produce CFU-GM-, BFU-E-, CFU-GEMM-, and HPP-CFC-derived colonies in a serum-containing methylcellulose assay s y~t e m .~,~ One nanogram of IL-3,10.0 ng KL, and 250.0 ng Epo/mL culture were used as sources of colonystimulating activity (CSA). Cultures initiated were incubated for 28 days at 37°C in 100% humidified 5% COz in air. CFU-GM-, BFU-E-, and CFU-GEMM-derived colonies were scored after 14 days, while HPP-CFC-derived colonies were scored after 28 days of culture, according to previously established morphologic crite-HPP-CFC-derived colonies are defined by both the colony size and time of appearance in culture as previously d e s~r i b e d .~~.~~ Human HPP-CFC have been shown by Srour et a1 to be capable of self-renewal and differentiation to multiple progenitor cells, indicative of their primitive nature.42
Sorted cells or cells obtained from LTBMC were assayed for their ability to produce CFU-MK-or BFU-MK-derived colonies in a serum-depleted fibrin clot assay ~y s t e m .~~,~ One nanogram of IL-3 and 10.0 ng KL/mL culture were used as sources of CSA. Cultures initiated were incubated for 14 or 21 days, at 37°C in 100% humidified 5% COz in air, to quantitate CFU-MK-and BFU-MK-derived colonies, respectively. After incubation, fibrin clots were fixed in situ in methano1:acetone 
Statistical Analysis
Results are expressed as the mean 2 SD of data obtained from multiple, separate experiments. Statistical significance was determined using the Student's t-test. showed that 6.5% +-1.4% of these FR 12-14 cells expressed CD34 (CD34+). In Fig 1, a representative levels of the KR (SR-1+) (Fig 1) . In Fig 2A, it is shown that cells that lacked expression of CD34 were not reactive with SR-1. Furthermore, cells that react with SR-1 all expressed CD34 (Fig 2B) . Similar results were obtained upon analysis of marrow cells obtained from two additional donors. The CD34+ cells that expressed HLA-DR and those that lacked the expression of HLA-DR were then analyzed for KR expression. The distribution percentages of the KR on CD34+ HLA-DR-and CD34+ HLA-DR+ cells on three separate BM specimens are shown in Table 1 . More than one-third of the CD34+ HLA-DR-cells expressed the KR, whereas more than one-half of the CD34+ HLA-DR+ cells were SR-1+ (Table 1) .
RESULTS
Initially
A morphologic analysis of the four CD34+ marrow subpopulations from two separate BM donors, fractionated on the basis of HLA-DR and KR expression, is provided in Table 2 . Cell populations expressing the KR (CD34+ HLA-DR-SR-1+, CD34+ HLA-DR+ SR-1+) largely resembled blast cells (Table 2) . Cell populations not expressing the KR (CD34+ HLA-DR-SR-1-, CD34+ HLA-DR+ SR-1-) contained more differentiated myeloid elements (Table 2 ). There were no observable MK elements present in any of the populations analyzed (data not shown).
All four cell populations were directly assayed for hematopoietic progenitor cell enrichment (CFU-GM, BFU-E, CFU-GEMM, CFU-MK, BFU-MK, HPP-CFC). In Table  3 , the progenitor cell enrichment of each population is shown. The majority of the most primitive progenitor cells, the BFU-MK and HPP-CFC, were detected in the CD34+ HLA-DR-SR-1+ population ( Table 3 ). The majority of the more differentiated progenitor cells, the CFU-GM, BFU-E, CFU-GEMM, and CFU-MK, were present in the CD34+ HLA-DR+ SR-1+ cell population (Table 3) . CD34+ HLA-DR+ SR-1+ cells had a cloning efficiency of 31.4%, whereas the CD34+ HLA-DR-SR-1+ cell population had an overall 7.3% cloning efficiency. Although the CD34+ HLA-DR+ SR-1-cell population contained significant numbers of progenitor cells (16.9% cloning efficiency), the numbers were far less than its SR-1+ counterpart.
Our laboratory has previously shown that CD34+ HLA-DR-cells are responsible for initiating L T B M C S .~,~~,~~ We attempted to determine whether the CD34+ HLA-DRcells possessing this ability express the KR. The cellular production by each type of LTBMC (CD34+ HLA-DR-SR-1-, CD34+ HLA-DR-SR-1+) over a 12-week period is shown in Fig 3. LTBMs initiated with CD34+ HLA-DRcells expressing the KR produced greater than 25 times the number of cells (2.5 x 106) as LTBMCs initiated with cells lacking KR expression (1.0 x 105). This number represents a 250-fold increase in cell number when compared with the starting cellular inoculum (1.0 X lo4) (Fig 4) .
The ability of these LTBMCs to produce assayable progenitor cells is shown in Figs 4, 5, and 6. The CD34+
HLA-DR-SR-1 +-initiated LTBMCs produced greater than 6.0 x 103 CFU-GM during the period of culture, indicating a greater than 10-fold increase in the number of these progenitor cells from the initial cellular inoculum (550.0 +: 50.0) (Fig 4) . In Fig 5A and B, progenitor cell production of other lineages is shown for both LTBMCs. Far greater production of BFU-E, CFU-GEMM, and CFU-MK was observed in the LTBMC initiated with CD34+ HLA-DR-SR-1+ cells (Fig 5A and B) . BFU-E and CFU-GEMM production by these cultures was sustained for 4 weeks, whereas CFU-MK generation persisted for 10 weeks. In Fig 6 , the number of assayable HPP-CFC generated during the period of culture is shown. The CD34+ HLA-DR-SR-1+ subpopulation was solely responsible for HPP-CFC production (Fig 6) . In fact, the CD34+ HLA-DR-SR-1 +-initiated LTBMCs generated nearly a threefold increase in HPP-CFC numbers over the initial cellular inoculum (708.0 -r-70.0) (Fig 6) .
DISCUSSION
The anatomy and physiology of human hematopoiesis is extremely complex. To further dissect the central mechanisms that lead to effective, sustained blood cell production, the properties of the human HSC and HSC-derived progen- KL is, in part at least, a direct one because marrow accessory cells are not required for this synergistic action. 16-z9,30-32,79 The breadth of response of KL on progenitor cells of various lineages, in addition to its action on the HPP-CFC and LTBMC-IC, suggests that the true human HSC might express the KR. This hypothesis does not eliminate the possibility of the existence of an even more primitive cell, a human pre-HSC that lacks KR expression. Our ability to define the existence of this cell might potentially be limited by the availability of assays to detect such a cell.
With these reservations in mind, we and others have proposed to use anti-KR antibodies to further isolate human hematopoietic progenitor ~e l l s .~~,~~ The availability of MoAbs to the human KR have only now made this approach fea~ible.3~9~~ Ashman et aP8 and Papayannopou-IOU et a137 have already used such reagents to initially characterize KR-expressing cells present in normal adult and fetal hematopoietic tissues. In the present report, additional information concerning the KR status on human BM cells is provided. These data indicate the scope of expression of KR on both primitive and differentiated human hematopoietic progenitor cells and indicate the potential use of such antireceptor antibodies as a means of further purifying candidate stem and progenitor cells. For personal use only. on October 24, 2017. by guest www.bloodjournal.org From that LTBMCs initiated from CD34+ HLA-DR-cells were but also produced a twofold to threefold expansion in HPP-CFC numbers during the period of c~l t u r e .~,~~ The present data suggest that the pre-HPP-CFC that leads to this expansion of HPP-CFC in LTBMC is SR-1+. The sustained production of HPP-CFC for up to 6 weeks in these LTBMCs indicates that self-renewal of Hpp-CFC likely occurs during the period of culture.
-
These experiments demonstrate the expression of KR on human hematopoietic progenitor cells present throughout the hierarchy of hematopoietic development. We conclude from our data that KL and KR not only are important regulators of more differentiated classes of human hematopoietic progenitor cells but also play a pivotal role in cytokine regulation of the most primitive classes of human hematopoietic progenitor cells. TWO populations of BM cells were isolated that predominantly contained distinct classes of progenitor cells. The CD34+ HLA-DR+ SR-1+ cells were enriched to the greatest extent for differentiated progenitor cells (CFU-GM, B W -6 CFU-GEMM, and CW-MK). This marrow subpopulation contained an extremely high cloning efficiency for these committed progenitor cells. These data confirm the findings of others that indicate that such progenitors express the KR.36-38
The presence of KR on the BW-MK, HPP-CFC, and LTBMC-IC was also demonstrated. The BW-MK and HPP-CFC are already known to be CD34+ H L A -D R -.~T~~ Between 80% and 90% of these progenitors were shown to express the KR (Table 2) . Whether functional differences exist between the SR-1-and SR-1+ BFU-MK or HPP-ACKNOWLEDGMENT CFCS Or whether the SR-1-BW-MK or HPP-CFCs precede their SR-1+ counterparts in the hierarchy of stem cell development is unknown.
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